Statin TReatment for COVID-19 to Optimise NeuroloGical recovERy

NCT04904536 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

190

Enrollment

OTHER

Sponsor class

Conditions

Neurocognitive Impairment, Mild

Interventions

DRUG: Atorvastatin
OTHER: Standard Care

Sponsor

The George Institute

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]